Toxicogenomics research consortium sails into uncharted waters. by Medlin, Jennifer
In the current state of gene expression tech-
nology, there are various methodologies for
assessing gene expression, making it difficult
to compare and compile data across labora-
tories and investigators. To stretch research
dollars and coordinate research efforts
among scientists who are using genomics to
better understand environmental effects on
human health, the NIEHS Division of
Extramural Research and Training last year
funded a $37 million partnership called the
Toxicogenomics Research Consortium
(TRC). The idea is simple, yet powerful:
the synchronization of research efforts of
many scientists in various locations
promises to produce high-quality
results faster and more reliably
than isolated research teams
working alone.
This consortium merges
the efforts of investigators
with similar environmental
health research goals from
the NIEHS Microarray
Center and five of the
country’s leading academic
research institutions: the
University of North Carolina
(UNC) at Chapel Hill, Duke
University in Durham, North
Carolina, the Fred Hutchinson
Cancer Research Center/University of
Washington (UW) in Seattle, the
Massachusetts Institute of Technology
(MIT) in Cambridge, and Oregon Health
& Science University (OHSU) in Portland.
Each of the five academic institutions will
receive $7.5 million over five years.
The consortium is charged with defin-
ing sites of genetic variability, developing
standards for gene expression experiments,
and applying gene expression technology
to study environmental stress responses in
biological systems. These efforts are criti-
cal for defining how environmental agents
cause disease, identifying biomarkers of
disease, predicting chemical toxicity, and
understanding why individuals show such
a wide variability in their sensitivity to
environmental toxicants. 
Consortium research projects fall
within the realm of environmental toxi-
cogenomics. This emerging discipline of
toxicology enables scientists to identify
and characterize the genomic signatures
of environmental toxicants, as well as use
gene and protein expression profiles to
study the relationship between exposure
and disease and understand gene–envi-
ronment interactions and their impact on
human health. 
Research among the Academic Partners
At Fred Hutchinson/UW, principal inves-
tigator Helmut Zarbl is leading efforts
using DNA microarrays to determine
whether particular genes are sensitive to
the actions of chemical toxicants and the
role of these genes in cancer development.
Microarray technology enables researchers
to measure the transcription of multitudes
of genes simultaneously on tiny
microchips containing thousands of targets
of complementary DNA (cDNA) or syn-
thetic DNA segments
(oligonucleotides)
immobilized
in a preset
arrange-
ment.
Zarbl’s
group is stud-
ying rat strains
with different sus-
ceptibilities to mam-
mary carcinogenesis to
help identify which differentially expressed
genes are related to the mechanims of sensi-
tivity. “The ultimate goal is to predict an
individual’s risk of cancer based on [his or
her] genetic profile and environmental
exposures,” says Zarbl, a member of the
center’s Human Biology and Public Health
Sciences Divisions and an affiliate associate
professor of pathology, environmental
health, and toxicology at UW. 
In other studies at Fred Hutchin-
son/UW, researchers hope to better under-
stand how environmental factors—metal
exposure, nutritional changes, and physical
factors such as hyperthermia due to mater-
nal fever—can damage the developing ner-
vous system, and how exposures to certain
organophosphates used in pesticides can
affect child behavior. Other projects seek to
develop tests to measure toxic exposure and
stress responses using lab-cultured liver cells.
Researchers at OHSU are collaborating
with the Boston Biomedical Research
Institute to compare gene and protein
expression patterns of nervous system cells
in both normal and toxicant-exposed states.
Under the direction of OHSU principal
investigator Peter Spencer, they hope to
increase understanding of the mecha-
nisms underlying toxic diseases of nerve
cells and their axons, as well as clarify
ways to screen for environmental agents
and hazards that have the potential to
cause neurodegeneration. 
“Toxicogenomics should allow us to
rapidly identify changes in the genome and
proteome [all the proteins expressed by a
genome], giving us a ‘fingerprint’ of the
effect of a particular chemical,” explains
Spencer, a professor of neurology in
OHSU’s School of Medicine and direc-
tor and senior scientist at the uni-
versity’s Center for Research
on Occupational and En-
vironmental Toxicology
(CROET). That fin-
gerprint, or gene
expression profile, he
says, allows the team
to see if classes of
chemicals are work-
ing to produce a par-
ticular toxicological
effect. 
CROET research-
ers have exposed mice to
two isomers of diacetyl-
benzene, one neurotoxic
and the other not, hoping to
assess gene modulation and isolate
the neurotoxic component. By looking
at the common gene expression signatures
expressed by both agents, they can subtract
a portion of each signature, leaving only
the shared portion, which reflects changes
caused by the neurotoxic element. This ele-
ment will be compared with the neurotoxic
signature of homologous neurotoxic chemi-
cals to determine whether commonalities
can be identified.
A second OHSU project will study the
effects of a potent genotoxin present in the
seed of the cycad, a tropical palm-like plant.
Cycad seeds have been used for food and
medicines on three Pacific islands—Guam,
Papua, and the Kii peninsula of Honshu
Island, Japan—where disproportionately
high numbers of people have suffered from
lytigo-bodig, a rare condition that shares
symptoms with amyotrophic lateral sclerosis
(Lou Gehrig disease) and Parkinson and
Alzheimer diseases. “Understanding the
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neurodegenerative disease may shed light on
look-alike disorders worldwide,” says
Spencer. 
On the East Coast, Leona Samson heads
up a team of scientists at MIT who are
studying the effects of aflatoxin B1 (which is
secreted by mold that grows on grains and is
associated with liver cancer) as well as envi-
ronmental alkylating agents in various cell
types, including liver cells. “We’re using
model systems—animals or cells we know
have [well-defined] biological outcomes
when exposed to environmental agents—to
determine what we can say about the
toxicogenomic response,”
Samson says. “These
agents represent
toxic agents
found
in our external environment, our food sup-
ply, the endogeneous cellular environment,
and the cancer chemotherapy clinic.” 
Another MIT study involves engineer-
ing liver cells to create liver “bioreactors”
that process toxic compounds. These three-
dimensional structures secrete the protein
albumin and even reproduce the force and
sheer caused by blood flow, allowing them
to mimic how the liver actually functions in
a living body. Using the engineered version,
scientists will be able to explore how the
human liver might respond to toxic insult. 
At UNC, researchers from the
Lineberger Comprehensive Cancer Center
and the Center for Environmental Health
and Susceptibility will study profiles of
genetic susceptibility to toxicant stress. Led
by William K. Kaufmann, a professor of
pathology and laboratory medicine in the
School of Medicine, UNC researchers are
using microarrays to study known environ-
mental and clinical carcinogens as well as
nongenotoxic carcinogens, which
appear to induce cancer
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damage. “A protein inside the cells inter-
acts with the compound through specific
receptors, which accounts for some or all
of its toxicity,” explains Kaufmann. 
In other UNC studies, researchers will
compare gene expression changes in mam-
mary epithelial cells after treatment with
various breast cancer therapies, focusing on
what appear to be overlapping responses.
They will evaluate how genetically pure
mouse strains differ in their response to
alkylating agents, watching for clues about
the genetic predisposition within families
to developing a particular cancer.
Researchers from Duke University’s
School of Medicine and the Nicholas
School of the Environment and Earth
Sciences, led by David A. Schwartz, a pro-
fessor of pulmonary and critical care medi-
cine, will watch how novel genes influence
an organism’s ability to defend itself
against endotoxins, cell wall components
of gram-negative bacteria. “So far, we’ve
found that there are several important
genes expressed that appear to genetically
regulate the response to endotoxin,” says
Schwartz.
A second group of researchers at Duke
is studying gene expression in developing
zebrafish to see how certain components of
retinoic acid synthesis and breakdown
pathways are expressed in the neural tube.
In a human component of this research,
investigators have been studying how vari-
ants of the associated genes relate to neural
tube defects in children, with results so far
ruling out the retinoic acid pathway. 
A third project, still in development,
will bring together researchers from
Duke, Fred Hutchinson, and MIT to
study gene response to toxic metals in
four different model systems: human
cells, mice, zebrafish, and Caenorhabditis
elegans, a unique roundworm whose
genome is fully mapped. “The goal is to
identify genes relevant across model systems
that are common in all model systems,”
says Schwartz. “If exposure to toxic agents
moderates a gene response in an evolution-
arily conserved set of genes or stimulates
common gene pathways in multiple
species, then [that] narrows the biology of
the response,” he hypothesizes. “I’ve been
encouraged by the interest among [TRC
members] in working together to achieve
common goals,” he adds. “The cross-
species comparisons are only possible with
the cooperation of multiple scientists at
different locations.” 
No matter what they are studying, all
of the scientists participating in the consor-
tium must wrestle with the “huge question
of reproducibility,” Samson cautions. “We
must compare our results and see where
the variabilities come from,” she says. “Do
they come from certain genes or certain
array platforms?” She adds that member
scientists should develop initial standards
of procedure from the outset “to make
sure we’re all producing high-quality
data.” 
Research at the NIEHS Microarray
Center
Besides the university constituents, the
NIEHS Microarray Center participates in
the TRC as well. Center director Richard
Paules says the NIEHS group is studying
the mechanisms involved in nongenotoxic
carcinogens, the role that estrogenic com-
pounds play in genetic damage, and human
susceptibility syndromes and how oxidative
damage contributes to cancer development.
In the latter study, Paules says, “we’ll focus
less on tissue and more on mechanistic
pathways to find out the role of oxidative
stress in the cancer process. People with
inherited susceptibility to cancer lack the
p53 gene that generates cell-cycle check-
point arrest in DNA. These gene mutations
are involved in the DNA damage
response.” He hopes the group’s findings
will lead to better diagnoses and treatment
therapies for cancer patients. 
Paules is currently leading a study of
how rodent toxicants affect the gene
response in rat livers, kidneys, and periph-
eral lymphocytes in the blood. “We want to
know which exposures are related to disease
process effects, not just pharmacological
effects,” he explains. His group will also
search for phenotypic anchors of gene
expression changes: “We want to make sure
we have a very clear definition of the biology
of what’s going on in a particular organism,
by defining traditional toxicological parame-
ters and making sure gene expression
changes are linked to phenotypic changes in
the liver models.”
Paules looks forward to joining forces
with like-minded counterparts at the
other TRC member institutions. “Our
goal is to be very interactive and collabo-
rate not only with academic partners, but
industry as well,” he says. He believes
this goal will be facilitated by the
Chemical Effects in Biological Systems
“knowledge base” being developed by the
NCT together with the consortium [see
“Toxicogenomics: An Emerging Disci-
pline,” p. A750 this issue]. “It will con-
tain as much biological, chemical, and
toxicological information as possible
related to gene expression changes,” he
explains. “Our goal is to build a publicly
accessible database so we can do predic-
tive toxicology.” –Jennifer Medlin
Two Committees
Tackle
Toxicogenomics
The advent of toxicogenomics—an emerg-
ing scientific discipline that applies recent
advances in genomics to the field of toxi-
cology—promises to transform the way sci-
entists use genetic information to study the
effects of the environment on human
health. Although toxicogenomics may
enable researchers to assess the toxicity of
environmental pollutants and therapeutic
drugs far faster and more economically
than traditional methods allow, the field’s
rapid emergence and fast-paced develop-
ments have created a number of challenges
as well. 
To meet those challenges and navigate a
maze of potential technical, regulatory, ethi-
cal, and communication roadblocks, the
National Research Council (NRC) has
formed the Committee on Emerging Issues
and Data on Environmental Contaminants.
The committee is sponsored by the NIEHS,
but because representatives from federal agen-
cies can’t participate in NRC committees,
a 10-member Federal Liaison Group—
composed of representatives from key reg-
ulatory agencies such as the Food and
Drug Administration, the Environmental
Protection Agency, the Occupational
Safety and Health Administration, and the
National Institute for Occupational Safety
and Health—will work alongside the NRC
committee.
The NRC committee is composed of
22 experts gathered from academia, pri-
vate industry, public interest groups, the
legal community, and the field of
bioethics. Their mission is threefold: to
foster open communication among the
scientific community and other stake-
holders about emerging issues in the field
of toxicogenomics, to identify topics for
future scientific study, and to consider
how data generated by this rapidly evolv-
ing technology can best be used to
inform public policy and improve public
health. 
According to David Brown, staff assis-
tant to NIEHS director Kenneth Olden,
good communication among stakeholders is
absolutely essential. A lack of it can lead to
confusion and distrust over the actual impli-
cations of environmentally induced health
effects, as well as divert attention from the
science underlying a particular issue or
question. Some data, Brown says, might
cause unnecessary public alarm or escape
warranted public attention in the hands of
uninformed or overzealous members of the
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Olden Receives Environmental
Public Health Awards
media. Furthermore, media coverage,
combined with ensuing public reaction,
might unduly affect science policy. An
ongoing dialogue among stakeholders will
help researchers anticipate problems
before they arise and ensure that sound
scientific findings guide all decision making.
“We thought it would be very important
right up front to bring people together to
interpret what this data means and commu-
nicate it in a responsible way to the public,
news media, and other scientists,” Brown
explains. 
Roberta Wedge, program director for
risk analysis with the National Academies’
Board on Environmental Studies and
Toxicology, agrees that proper communica-
tion is key. “The [committees] will provide
a public forum for communication among
different groups on environmental toxicol-
ogy, risk assessment, exposure assessment,
toxicogenomics, proteomics, and bioinfor-
matics,” she says. Several times a year—
beginning with an inaugural symposium on
4 November 2002—the committees will
host open sessions featuring workshops,
guest speakers, and interactive panel discus-
sions. Regular newsletters and webcasts are
available on the committee’s website at
http://dels.nas.edu/emergingissues/. 
The committees’ most important dis-
cussions will most certainly lead to policy
development, Brown believes. “This is a
tremendous opportunity for anyone
involved in developing regulations using
risk assessment,” he claims. Marilee
Shelton, a program officer with the
National Academies’ Board on Life
Sciences, agrees: “The [committees] will
explore how scientific approaches might
influence policy and regulatory decisions,”
she says. Take, for example, changes in
gene expression detected with DNA
microarrays. Scientists and other parties
must not only assess toxicological implica-
tions of such changes, but also decide
whether those changes will truly result in
possibly adverse health effects in humans,
she cautions. “Regulatory agencies need to
think about what the biological measure-
ments mean.” 
Other challenges include analyzing
enormous quantities of microarray data,
standardizing research methods and
nomenclature, benchmarking newer toxi-
cogenomic methods against traditional
toxicological techniques, developing dis-
ease and exposure biomarkers, and extrap-
olating results from animal experiments
to humans—a tricky process at best. As
the field of toxicogenomics advances, its
ensuing challenges are certain to multiply.
These committees stand ready to meet
them head-on. –Jennifer Medlin
The American Public Health Association (APHA), the world’s oldest and
largest organization of public health professionals, awarded its prestigious
Calver Award to Kenneth Olden, director of the NIEHS and the National
Toxicology Program. The award was presented at the association’s annual
meeting, held 11 November 2002 in Philadelphia.
The award is named for Homer Calver, a World War I medic, public
health official, and environmental journalist. Calver was executive director
of the APHA and editor of its journal, the American Journal of Public
Health. He also established and edited the Environmental News Digest.
As a health officer in Winston-Salem, North Carolina, Calver brought
the city through a diphtheria epidemic and secured a modern ordinance
protecting the milk and food supply. Intrigued
by European health exhibits he saw on a trip in
1930, he used the APHA to promote American
exhibits combining accurate health information
with showmanship. One such exhibit, “The
Transparent Man,” was visited at the 1939 New
York World’s Fair by 12 million people, a
record for a health exhibit that has yet to be
broken. The Calver Award was established in
1970, the year Calver died (and the year Earth
Day was first observed).
In announcing Olden’s award, APHA chair
for the environmental section Captain Patrick
O. Bohan (Retired) of the U.S. Public Health
Service said, “The APHA’s environmental sec-
tion is pleased to recognize the tremendous
accomplishments of Kenneth Olden over his more than ten years as director
of the NIEHS and NTP, and over his decades in biomedical research. He has
deepened the science of his agency at the same time he has broadened its
relevance to public health. The recognition is richly deserved.”
Since his appointment as director of the NIEHS in 1991, Olden has
become a national spokesperson for improved public health through envi-
ronmental health sciences, with special emphasis on partnerships with
grassroots organizations and patient advocacy groups in charting programs
of environmental research. He initiated NIEHS-sponsored town meetings
throughout the nation that have been public sounding boards focusing on
regional environmental health concerns as well as health effects specific to
minorities and those of lower socioeconomic status that are caused by
exposure to environmental pollutants.
Olden has also taken a leading role in founding the Environmental
Genome Project to study individual susceptibility to environmental insults,
and the National Center for Toxicogenomics, which applies advances in
genetic technology to chemical testing studying environmentally related
disease. As recipient of the Calver Award, Olden delivered the keynote
address at the APHA’s environmental section program at the annual
meeting.
In another announcement, Olden has also been awarded the first
Cincinnati Children’s Environmental Health Award, presented by the
Cincinnati Area Lead Advisory Committee (CALAC). The award, presented in
November at a reunion of families who have participated in local lead stud-
ies, acknowledges Olden’s leadership role in addressing children’s health
issues, especially lead poisoning, and recognizes the role of the NIEHS in a
number of children’s health initiatives that have enhanced children’s health
in the Cincinnati area. CALAC is working with the local Community Lead
Education and Reduction/AmeriCorps, or CLEARCorps, program to increase
community awareness of lead hazards and lobby for passage of a local lead
hazard control ordinance.
Kenneth OldenBetween 5 December and 9 December
1952, one of the deadliest recorded
episodes of urban smog occurred in
London, England. New research indicates
that as many as 12,000 people may have
died as a result of the smog, and mortality
from respiratory illnesses such as bronchitis
and pneumonia increased more than seven-
fold during the smog. Overall death rates
during the first half of that month were
three times higher than normal, and
morbidity and mortality rates in greater
London remained elevated well into
March of 1953.
The severity of the 1952 London
Smog, along with the publicity sur-
rounding it and other smog episodes in
the early twentieth century, had two
effects. First, they sparked an increased
public health effort to understand the
effects of air pollution on human
health. Second, they prompted the for-
mulation of governmental regulations
on air pollution in many countries.
This milestone event in the history of
environmental health will be com-
memorated at the conference “The Big
Smoke: Fifty Years after the 1952
London Smog,” cosponsored by the
NIEHS along with the Health Effects
Institute, the Wellcome Trust, the
Greater London Authority, the
London borough of Camden, Sypol (a
British environmental health and safety
consulting group), the Shell Foun-
dation, and the International Society
for Environmental Epidemiology.
Organized by Tony Fletcher and
Virginia Berridge, professors of envi-
ronmental epidemiology and history,
respectively, at the London School of
Hygiene and Tropical Medicine, the con-
ference will be held 9–10 December 2002
at the University of London.
Programs will include historical per-
spectives of the 1952 London Smog and of
air pollution in London in general. London
had experienced smog events since the
twelfth century, when coal was discovered
along England’s northeast coast and
became the fuel of choice. But such events
increased during and after the Industrial
Revolution as both manufacturing and the
population—both then dependent on
burning large amounts of coal—expanded
dramatically in the city.
For much of November 1952, tempera-
tures in southern England were unusually
low, causing people to heavily stoke their
coal-burning home furnaces to keep warm.
In the first days of December, high atmos-
pheric pressure over the area caused an
inversion that trapped soot and other air
pollutants near ground level. Because of the
smog, visibility in some areas of central
London was reduced to nearly zero for 48
hours. Measurements taken at the time
revealed that during that first week of
December 370 metric tons of sulfur dioxide
were released into the air, where it was con-
verted into sulfuric acid. Large amounts of
particulate matter also were released. 
One seminar at the conference will
bring together physicians, researchers, and
others who remember the 1952 smog to
present their eyewitness accounts of the
event. These accounts will eventually be
compiled into a book by historians at the
London School of Hygiene and Tropical
Medicine.
Other presentations will discuss the
health impacts of the 1952 smog and the
public health response. A presentation by
Devra Davis, a visiting professor of public
policy at Carnegie Mellon University, will
offer a reanalysis of how public health
officials handled the event at the time and
new evidence indicating that as many as
12,000 deaths may have resulted from the
smog. As she wrote in her recently
released book When Smoke Ran Like
Water: Tales of Environmental Deception
and the Battle against Pollution, “The true
toll of London’s smog was hidden for
years within official documents. . . . In the
1950s in London and elsewhere, public
health statistics were only just starting to
be retrievable for use in research.”
Even though levels of sulfur dioxide
and smoke in London have greatly
decreased over the past 50 years, particu-
late matter remains a significant pollutant,
and high levels of other air pollutants such
as nitrogen dioxide are being detected,
with London residents again experiencing
significant winter pollution episodes
during 1991, 1994, and 1997. David
Hutchinson, an adviser with the
Greater London Authority (which over-
sees economic development and public
transportation), will present the current
governmental strategy for improving air
quality in the city. The plan includes a
number of large-scale public transporta-
tion and energy initiatives. Proposals
include increasing the number of pri-
vately owned alternative-fuel vehicles
and creating low-emission zones in the
city that would bar the most-polluting
vehicles from those areas.
Another session will focus on the
health effects of urban air pollution
worldwide and air pollution episodes
caused by vegetation fires. One grow-
ing urban center, Dublin, Ireland, has
learned a great deal about managing air
pollution. A study cofunded by the
NIEHS, conducted by researchers at
the Harvard School of Public Health,
and published in the 19 October 2002
issue of The Lancet, found that a 1990
ban on coal sales and coal burning in
Dublin has resulted in a 70% decrease
in concentrations of black smoke (fine
suspended particulate matter), a 15.5%
reduction in deaths from respiratory caus-
es, and a 10.3% reduction in deaths from
cardiovascular causes. Michael Brauer, a
professor in the School of Occupational and
Environmental Hygiene at the University of
British Columbia in Vancouver, believes the
spread of urban areas into formerly forested
or agricultural regions is a key factor in the
rising incidence of air pollution episodes
and human health effects from vegetation
fires worldwide.
Although 50 years have passed since the
Great London Smog, many people alive at
the time vividly remember the smog-
choked streets and shrieking ambulance
sirens from those days. But thanks to the
public outcry following the 1952 smog,
they have also witnessed a significant
improvement in air quality, public health
policy, and government regulation in many
countries that has greatly reduced the threat
of future smog episodes. –Erin E. Dooley
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Fifty Years Later: Clearing the Air over the London Smog
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Thick as pea soup. A man uses a lit torch to guide a bus
through the blinding 1952 London Smog.